Consun Pharmaceutical Group Ltd (HKSE:01681) Share Price

Company Profile

Business description
Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.
Contact
71, Dongpeng Avenue
Eastern section
Guangzhou Economic and Technological Development
Guangzhou
CHN
T: +86 2082264529
https://www.chinaconsun.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
3,073

Recommended

Demographic challenges in A2’s largest market lead to sell-off.

Angus Hewitt, CFA | 20 January 2026

Cost-cutting the priority as underlying asset values falling on deaf ears.

Brian Han | 19 January 2026

We raise our fair value estimate for Goldman Sachs stock.

Sean Dunlop, CFA | 18 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,108.60	16.20	0.18%
CAC 40	8,030.65	31.93	-0.40%
DAX 40	24,406.80	296.32	-1.20%
Dow JONES (US)	48,488.59	870.74	-1.76%
FTSE 100	10,112.54	14.24	-0.14%
HKSE	26,585.06	97.55	0.37%
NASDAQ	22,954.32	561.07	-2.39%
Nikkei 225	52,774.64	216.46	-0.41%
NZX 50 Index	13,417.17	156.76	-1.15%
S&P 500	6,796.86	143.15	-2.06%
S&P/ASX 200	8,782.90	14.00	0.16%
SSE Composite Index	4,116.94	3.29	0.08%